You are here

ALK-Abello

With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M

Fierce Pharma

Mon, 11/11/24 - 11:28 am

ARS Pharmaceuticals

epinephrine nasal spray

Merck Calls Time On U.S. Allergy Market

Seeking Alpha

Thu, 07/28/16 - 09:04 am

ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint

Pharmabiz

Sat, 07/13/13 - 12:41 pm

3 Promising Treatments for a Surprisingly Common Health Problem

Motley Fool

Sun, 05/5/13 - 10:54 am

allergic rhinitis

Ragweed Allergy

Merck says pill tames allergic response to ragweed

Reuters

Sun, 03/4/12 - 12:10 pm